Frequency and distribution pattern of distant metastases in patients with ENT tumors and their consequences for pretherapeutic staging;Häufigkeit und topographie von fernmetastasen bei patienten mit HNO-tumoren und ihre konsequenzen für das prätherapeutische staging

Strahlentherapie und Onkologie

Volumn 183, Issue 3, 2007, Pages 138-143

  Dietl, Barbara ^a   Marienhagen, Jörg ^a   Schaefer, Christof ^a   Pohl, Fabian ^a   Kölbl, Oliver ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Distant metastases; ENT tumors; Second primary tumors; Staging

Indexed keywords

ADULT; ADVANCED CANCER; ARTICLE; BONE METASTASIS; BRAIN METASTASIS; BRONCHUS TUMOR; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER STAGING; CANCER THERAPY; CONTROLLED STUDY; FEMALE; HEAD AND NECK TUMOR; HISTOPATHOLOGY; HUMAN; HYPOPHARYNX CARCINOMA; HYPOPHARYNX TUMOR; LARYNX TUMOR; LIVER METASTASIS; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; MOUTH TUMOR; OROPHARYNX TUMOR; PLEURA METASTASIS; RETROSPECTIVE STUDY; SECOND CANCER; SKIN METASTASIS; SQUAMOUS CELL CARCINOMA; TUMOR LOCALIZATION;

CARCINOMA, BRONCHOGENIC; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; FEMALE; HUMANS; LUNG NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; NEOPLASMS, MULTIPLE PRIMARY; NEOPLASMS, SECOND PRIMARY; OTORHINOLARYNGOLOGIC NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33847651700     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00066-007-1611-7     Document Type: Article

References (33)

1. Al Othman MO, Morris CG, Hinerman RW, et al. Distant metastases after definitive radiotherapy for squamous cell carcinoma of the head and neck. Head Neck 2003;25:629-33.
2. Beckmann GK, Hoppe F, Pfreundner L, et al. Hyperfractionated accelerated radiotherapy in combination with weekly cisplatin for locally advanced head and neck cancer. Head Neck 2005;27:36-43.
3. Berger DS, Fletcher GH. Distant metastases following local control of squamous-cell carcinoma of the nasopharynx, tonsillar fossa, and base of the tongue. Radiology 1971;100:141-3.
4. Bonner JA, Harari PM, Giralt J, et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 2006;354:567-78.
5. Calhoun KH, Fulmer P, Weiss R, et al. Distant metastases from head and neck squamous cell carcinomas. Laryngoscope 1994;104:1199-205.
6. De Bree R, Deurloo EE, Snow GB, et al. Screening for distant metastases in patients with head and neck cancer. Laryngoscope 2000;110:397-401.
7. De Crevoisier R, Domenge C, Wibault P, et al. Full dose reirradiation combined with chemotherapy after salvage surgery in head and neck carcinoma. Cancer 2001;91:2071-6.
8. Dietl B, Marienhagen J, Kuhnel T, et al. FDG-PET in radiotherapy treatment planning of advanced head and neck cancer - a prospective clinical analysis. Auris Nasus Larynx 2006;33:303-9.
9. Ferlito A, Shaha AR, Silver CE, et al. Incidence and sites of distant metastases from head and neck cancer. ORL J Otorhinolaryngol Relat Spec 2001;63:202-7.
10. Hao D, Ritter MA, Oliver T, et al. Platinum-based concurrent chemoradiotherapy for tumors of the head and neck and the esophagus. Semin Radiat Oncol 2006;16:10-9.
11. Haughey BH, Gates GA, Arfken CL, et al. Meta-analysis of second malignant tumors in head and neck cancer: the case for an endoscopic screening protocol. Ann Otol Rhinol Laryngol 1992;101:105-12.
12. Jackel MC, Rausch H. [Distant metastasis of squamous epithelial carcinomas of the upper aerodigestive tract. The effect of clinical tumor parameters and course of illness.] HNO 1999;47:38-44.
13. Kotwall C, Sako K, Razack MS, et al. Metastatic patterns in squamous cell cancer of the head and neck. Am J Surg 1987;154:439-42.
14. Kovacs AF, Mose S, Bottcher HD, et al. Multimodality treatment including postoperative radiation and concurrent chemotherapy with weekly docetaxel is feasible and effective in patients with oral and oropharyngeal cancer. Strahlenther Onkol 2005;181:26-34.
15. Leon X, Quer M, Diez S, et al. Second neoplasm in patients with head and neck cancer. Head Neck 1999;21:204-10.
16. Leon X, Quer M, Orus C, et al. Distant metastases in head and neck cancer patients who achieved loco-regional control. Head Neck 2000;22:680-6.
17. List MA, Bilir SP. Functional outcomes in head and neck cancer. Semin Radiat Oncol 2004;14:178-89.
18. Lybak S, Olofsson J. Ultrasound of the abdomen and total bone scintigraphy in patients with cancer of the head and neck. Eur Arch Otorhinolaryngol 2005;262:887-9.
19. Moertel CG. Incidence and significance of multiple primary malignant neoplasms. Ann N Y Acad Sci 1964;114:886-95.
20. Nagar YS, Singh S, Datta NR. Chemo-reirradiation in persistent/recurrent head and neck cancers. Jpn J Clin Oncol 2004;34:61-8.
21. Patel SG, Shah JP. TNM staging of cancers of the head and neck: striving for uniformity among diversity. CA Cancer J Clin 2005;55:242-58.
22. Pietropaoli MP, Damron TA, Vermont AI. Bone metastases from squamous cell carcinoma of the head and neck. J Surg Oncol 2000;75:136-41.
23. Pignon JP, Bourhis J, Domenge C, et al. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer. Lancet 2000;355:949-55.
24. Pivot X, Kataja VV, Jelic S. ESMO minimum clinical recommendations for diagnosis, treatment and follow-up of squamous cell carcinoma of the head and neck (SCCHN). Ann Oncol 2005;16:Suppl 1:i62-3.
25. Reiner B, Siegel E, Sawyer R, et al. The impact of routine CT of the chest on the diagnosis and management of newly diagnosed squamous cell carcinoma of the head and neck. AJR Am J Roentgenol 1997;169:667-71.
26. Salz H, Wiezorek T, Scheithauer M, et al. IMRT with compensators for head-and-neck cancers. Treatment technique, dosimetric accuracy, and practical experiences. Strahlenther Onkol 2005;181:665-72.
27. Schwartz DL, Rajendran J, Yueh B, et al. Staging of head and neck squamous cell cancer with extended-field FDG-PET. Arch Otolaryngol Head Neck Surg 2003;129:1173-8.
28. Spector GJ. Distant metastases from laryngeal and hypopharyngeal cancer. ORL J Otorhinolaryngol Relat Spec 2001;63:224-8.
29. Strnad V, Geiger M, Lotter M, et al. The role of pulsed-dose-rate brachytherapy in previously irradiated head-and-neck cancer. Brachytherapy 2003;2:158-63.
30. Tokuuye K, Akine Y, Kagei K, et al. Proton therapy for head and neck malignancies at Tsukuba. Strahlenther Onkol 2004;180:96-101.
31. Troell RJ, Terris DJ. Detection of metastases from head and neck cancers. Laryngoscope 1995;105:247-50.
32. Wiezorek T, Banz N, Schwedas M, et al. Dosimetric quality assurance for intensity-modulated radiotherapy. Feasibility study for a filmless approach. Strahlenther Onkol 2005;181:468-74.
33. Wiggenraad R, Mast M, van Santvoort J, et al. ConPas: a 3-D conformal parotid gland-sparing irradiation technique for bilateral neck treatment as an alternative to IMRT. Strahlenther Onkol 2005;181:673-82.